Molina Healthcare (NYSE:MOH – Get Free Report) is expected to be posting its Q3 2026 results after the market closes on Wednesday, October 21st. Analysts expect the company to post earnings of $0.79 per share and revenue of $10.86 billion for the quarter. Interested persons can check the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, October 22, 2026 at 8:00 AM ET.
Molina Healthcare (NYSE:MOH – Get Free Report) last released its quarterly earnings data on Wednesday, July 22nd. The company reported $1.51 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.12. Molina Healthcare had a negative net margin of 0.02% and a positive return on equity of 3.73%. The firm had revenue of $10.87 billion for the quarter, compared to the consensus estimate of $10.83 billion. During the same quarter in the prior year, the company posted $5.48 earnings per share. The business’s revenue was down 4.8% on a year-over-year basis. On average, analysts expect Molina Healthcare to post $5.28 EPS for the current fiscal year and $9.76 EPS for the next fiscal year.
Molina Healthcare Stock Up 1.6%
Molina Healthcare stock opened at $210.58 on Tuesday. The firm has a market capitalization of $10.99 billion, a price-to-earnings ratio of 70.29, a price-to-earnings-growth ratio of 29.73 and a beta of 0.78. The firm’s fifty day moving average price is $199.79 and its two-hundred day moving average price is $194.39. Molina Healthcare has a 1-year low of $121.06 and a 1-year high of $244.89. The company has a current ratio of 1.68, a quick ratio of 1.68 and a debt-to-equity ratio of 0.95.
Wall Street Analyst Weigh In
Several equities research analysts have recently commented on MOH shares. Truist Financial decreased their target price on shares of Molina Healthcare from $250.00 to $225.00 and set a “hold” rating for the company in a research report on Friday, July 24th. Wall Street Zen cut shares of Molina Healthcare from a “hold” rating to a “sell” rating in a research report on Sunday, October 4th. Weiss Ratings downgraded Molina Healthcare from a “sell (d+)” rating to a “sell (d)” rating in a research note on Tuesday, October 6th. Sanford C. Bernstein set a $286.00 price target on Molina Healthcare in a research note on Monday, July 13th. Finally, Royal Bank Of Canada decreased their price objective on Molina Healthcare from $248.00 to $218.00 and set a “sector perform” rating for the company in a report on Friday, July 24th. Three research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $202.44.
Check Out Our Latest Analysis on Molina Healthcare
Molina Healthcare Company Profile
Molina Healthcare, Inc is a managed-care company that provides health insurance and related services primarily through government-sponsored programs. Its offerings include Medicaid, Medicare, Medicare-Medicaid dual-eligible plans and health plans sold through government marketplaces under the Affordable Care Act.
The company’s services generally include medical care coordination, behavioral health support, pharmacy benefits and, depending on the plan and state, dental and vision benefits.
Read More
- Five stocks we like better than Molina Healthcare
- Tesla’s Roadster Reveal Hints at 2 Much Bigger Moves
- The AI Sell-Off Continues—These 3 Stocks Keep Raising Guidance Anyway
- Mr. Wonderful’s Test for AI Data Center Stocks: Power, Permits, and Tenants
- Alcoa Beat Earnings, But Can It Escape the Aluminum Bears?
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
